Published online 10 February 2003. doi:10.1083/jcb.200210164
© The Rockefeller University Press,
0021-9525/2003/2/481 $5.00
The Journal of Cell Biology, Volume 160, Number 4, 481-486
The FGF receptor uses the endocannabinoid signaling system to couple to an axonal growth response
Emma-Jane Williams1,
Frank S. Walsh2 and
Patrick Doherty1
1 Molecular Neurobiology Group, Medical Research Council Centre for Developmental Biology, King's College London, London SE1 1UL, UK
2 Discovery Research, Wyeth Research, Collegeville, PA 19426
Address correspondence to Patrick Doherty, Molecular Neurobiology Group, Medical Research Council Centre for Developmental Biology, King's College London, New Hunt's House, London Bridge, London SE1 1UL, UK. Tel.: 44-207-848-6813. Fax: 44-207-848-6816. E-mail: patrick.doherty{at}kcl.ac.uk
Akey role for DAG lipase activity in the control of axonal growth and guidance in vitro and in vivo has been established. For example, DAG lipase activity is required for FGF-stimulated calcium influx into neuronal growth cones, and this response is both necessary and sufficient for an axonal growth response. The mechanism that couples the hydrolysis of DAG to the calcium response is not known. The initial hydrolysis of DAG at the sn-1 position (by DAG lipase) will generate 2-arachidonylglycerol, and this molecule is well established as an endogenous cannabinoid receptor agonist in the brain. In the present paper, we show that in rat cerebellar granule neurons, CB1 cannabinoid receptor antagonists inhibit axonal growth responses stimulated by N-cadherin and FGF2. Furthermore, three CB1 receptor agonists mimic the N-cadherin/FGF2 response at a step downstream from FGF receptor activation, but upstream from calcium influx into cells. In contrast, we could find no evidence for the CB1 receptor coupling the TrkB neurotrophin receptor to an axonal growth response in the same neurons. The observation that the CB1 receptor can couple the activated FGF receptor to an axonal growth response raises novel therapeutic opportunities.
Key Words: CAM; CB1; 2-AG; cannabinoid; N-cadherin

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Aguado, T., Romero, E., Monory, K., Palazuelos, J., Sendtner, M., Marsicano, G., Lutz, B., Guzman, M., Galve-Roperh, I.
(2007). The CB1 Cannabinoid Receptor Mediates Excitotoxicity-induced Neural Progenitor Proliferation and Neurogenesis. J. Biol. Chem.
282: 23892-23898
[Abstract]
[Full Text]
-
Galve-Roperh, I., Aguado, T., Palazuelos, J., Guzman, M.
(2007). The Endocannabinoid System and Neurogenesis in Health and Disease. Neuroscientist
13: 109-114
[Abstract]
-
Kogan, N. M., Blazquez, C., Alvarez, L., Gallily, R., Schlesinger, M., Guzman, M., Mechoulam, R.
(2006). A Cannabinoid Quinone Inhibits Angiogenesis by Targeting Vascular Endothelial Cells. Mol. Pharmacol.
70: 51-59
[Abstract]
[Full Text]
-
Kiryushko, D., Korshunova, I., Berezin, V., Bock, E.
(2006). Neural Cell Adhesion Molecule Induces Intracellular Signaling via Multiple Mechanisms of Ca2+ Homeostasis. Mol. Biol. Cell
17: 2278-2286
[Abstract]
[Full Text]
-
Aguado, T., Palazuelos, J., Monory, K., Stella, N., Cravatt, B., Lutz, B., Marsicano, G., Kokaia, Z., Guzman, M., Galve-Roperh, I.
(2006). The Endocannabinoid System Promotes Astroglial Differentiation by Acting on Neural Progenitor Cells. J. Neurosci.
26: 1551-1561
[Abstract]
[Full Text]
-
Berghuis, P., Dobszay, M. B., Wang, X., Spano, S., Ledda, F., Sousa, K. M., Schulte, G., Ernfors, P., Mackie, K., Paratcha, G., Hurd, Y. L., Harkany, T.
(2005). Endocannabinoids regulate interneuron migration and morphogenesis by transactivating the TrkB receptor. Proc. Natl. Acad. Sci. USA
102: 19115-19120
[Abstract]
[Full Text]
-
Jin, K., LaFevre-Bernt, M., Sun, Y., Chen, S., Gafni, J., Crippen, D., Logvinova, A., Ross, C. A., Greenberg, D. A., Ellerby, L. M.
(2005). FGF-2 promotes neurogenesis and neuroprotection and prolongs survival in a transgenic mouse model of Huntington's disease. Proc. Natl. Acad. Sci. USA
102: 18189-18194
[Abstract]
[Full Text]
-
Bottcher, R. T., Niehrs, C.
(2005). Fibroblast Growth Factor Signaling during Early Vertebrate Development. Endocr. Rev.
26: 63-77
[Abstract]
[Full Text]
-
Jin, K., Xie, L., Kim, S. H., Parmentier-Batteur, S., Sun, Y., Mao, X. O., Childs, J., Greenberg, D. A.
(2004). Defective Adult Neurogenesis in CB1 Cannabinoid Receptor Knockout Mice. Mol. Pharmacol.
66: 204-208
[Abstract]
[Full Text]
-
Alberich Jorda, M., Rayman, N., Tas, M., Verbakel, S. E., Battista, N., van Lom, K., Lowenberg, B., Maccarrone, M., Delwel, R.
(2004). The peripheral cannabinoid receptor Cb2, frequently expressed on AML blasts, either induces a neutrophilic differentiation block or confers abnormal migration properties in a ligand-dependent manner. Blood
104: 526-534
[Abstract]
[Full Text]
-
Suzuki, M., Angata, K., Nakayama, J., Fukuda, M.
(2003). Polysialic Acid and Mucin Type O-Glycans on the Neural Cell Adhesion Molecule Differentially Regulate Myoblast Fusion. J. Biol. Chem.
278: 49459-49468
[Abstract]
[Full Text]
-
Bisogno, T., Howell, F., Williams, G., Minassi, A., Cascio, M. G., Ligresti, A., Matias, I., Schiano-Moriello, A., Paul, P., Williams, E.-J., Gangadharan, U., Hobbs, C., Di Marzo, V., Doherty, P.
(2003). Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. JCB
163: 463-468
[Abstract]
[Full Text]